×
-0.000102291325695633 0.000153436988543377 0.00299202127659579 0.00317103109656303 0.00291530278232402 0.00450081833060554 0.00863389934533547 0.0193330605564648
Stockreport

U.S. Supreme Court rejects Amgen over cholesterol medication patent fight [Reuters]

Amgen, Inc (AMGN)  More Company Research Source: Reuters
Last amgen, inc earnings: 1/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
PDF U.S. Supreme Court rejects Amgen over cholesterol medication patent fight WASHINGTON (Reuters) - The U.S. Supreme Court on Monday declined to take up Amgen Inc’s bid to reinstate a jury verdict it won against rivals Regeneron Pharmaceuticals Incand Sanofi SAin patent dispute over cholesterol medication. The justices turned away Amgen’s appeal of a 2017 decision by a lower court to set aside a jury’s verdict that two Amgen patents were valid and nullify a ban on sales of Regeneron and Sanofi SA’s cholesterol-lowering drug Praluent. Amgen had argued that the U.S. Court of Appeals for the Federal Circuit misunderstood the statutory requirements for patenting an invention. Reporting by Jan Wolfe and Lawrence Hurley; Editing by Will Dunham Our Standards: The Thomson Reuters Trust Principles. [Read more]

IMPACT SNAPSHOT EVENT TIME: AMGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
AMGN alerts
from News Quantified
Opt-in for
AMGN alerts

from News Quantified
Opt-in for
AMGN alerts

from News Quantified